3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Rosacea
1
Meibomian Gland Dysfunction
1
Chalazion
1
Interventions
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Biopsy
4
durvalumab
3
atezolizumab
3
Radiotherapy
3
Radiosurgery
3
Cyclophosphamide
3
Bevacizumab
3
palbociclib
2
niraparib
2
abemaciclib
2
Trastuzumab
2
Temozolomide
2
Taxes
2
Surgical Procedures, Operative
2
Specimen Handling
2
Melphalan
2
Letrozole
2
Ketamine
2
Irinotecan
2
Hydrocortisone
2
Gemcitabine
2
Fluorodeoxyglucose F18
2
Ferrosoferric Oxide
2
Dexamethasone
2
Curcumin
2
Blood Specimen Collection
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Withdrawn
×
Tetracycline
×
Clear all
NCT01763437
2017-01-12
TET
The Cleveland Clinic
Phase EARLY_PHASE1
Withdrawn